Skip to content

Comparison of the Swallowing Functions in Sarcopenia and Dynapenia

Comparison of the Swallowing Functions of the Sarcopenia and Dynapenia Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04960007
Enrollment
108
Registered
2021-07-13
Start date
2021-07-26
Completion date
2021-08-27
Last updated
2021-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia, Sarcopenia, Swallowing Disorder

Keywords

sarcopenia, dynapenia, swallowing, deglutition, dysphagia

Brief summary

The purpose of the study to investigate the comparison of the swallowing functions of the sarcopenia and dynapenia in older patients

Detailed description

Sarcopenia is a geriatric syndrome; from skeletal muscle, and in its usefulness. Dynapenia is a picture of sarcopenia without measurable muscle mass. It has been shown that dysphagia complaints are more common in patients with sarcopenia than in the normal population, but a comparison with patients with dynapenia has not been made to the best of our knowledge. According to the algorithm of The International Society of Physical and Rehabilitation Medicine (ISPRM), experts in the special interest group on sarcopenia, in the routine examination of patients aged 60-90 years who applied to the Physical Medicine and Rehabilitation outpatient clinic with complaints of decreased muscle function, weakness, and slow movement, or sarcopenia or Patients with dynapenia and patients without Sarcopenia disease who volunteered to participate in the study will be included in the order of application to the outpatient clinic.

Interventions

None listed

Sponsors

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 60-90 years * Sarcopenia and dynapenia patients in study groups * Non- sarcopenia and non-dynapenia patients in control groups * Patients who were accept to consent form

Exclusion criteria

* Severe sarcopenia patients * Cognitive limitations * Out of age 60-90 years old * Patients who were not accept to consent form

Design outcomes

Primary

MeasureTime frameDescription
The evaluation of eating and swallowing functionsBaselineThey were assessed by Eating Assessment Tool in participants. Composite Score ranges from 0 ( good) to 4 (worst). The minimum total score was 0 and the maximum total score was 40. The cut-off value was 3 points. High scores show worst eating and swallowing functions, and low quality of life.
The values of penetration and aspirationBaselineIt was assessed with Fiberoptic Endoscopic Evaluation of Swallowing. Fiberoptic Endoscopic Evaluation of Swallowing results were scored on the Penetration and aspiration scale. The scores of scale were between 1-8 points. The high points were worst, low points were good swallowing functions.
The values of Pharyngeal Residue SeverityBaselineIt was assessed with Fiberoptic Endoscopic Evaluation of Swallowing. Fiberoptic Endoscopic Evaluation of Swallowing results were scored on Yale Pharyngeal Residue Severity Rating scale. The scores of scale were none, trace, mild, moderate, and severe. The high-grade symptom scores were worst, low scores were good swallowing functions.
The values of muscle massBaselineThe diameters of tigh were measured with tailor meter by a Physical Medicine and Rehabilitation professionals (measure unit is cm).
The evaluation of depressionBaselineThey were assessed by Geriatric Depression Scale in participants. The scores between 0-10 were no depression, between 11-13 points were probably depression, and higher of 14 points were exact depression.
The values of muscle strengthBaselineThey were assessed as newton by hand grip device.

Secondary

MeasureTime frameDescription
Mean of demographicBaselineAge, gender, history of smoke, history of morbidities, diagnosis, stage, were noted

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026